Market Overview

Calls Sold on Celldex Therapeutics (CLDX)

Shares of Celldex Therapeutics Inc. (NASDAQ: CLDX) are markedly lower on the session by 16.77%, currently trading $5.46. The stock is sinking after the company provided color on their current breast cancer study.

Calls are being largely sold on the name today. The June $7.50 call was just sold over 4,500 times on the offer; open interest on the strike is 7,643 contracts, indicating that a long call position was likely closed.

Call volume is running at 2.42x the daily average.

Celldex Therapeutics, Inc. is a biopharmaceutical company, which applies its Precision Targeted Immunotherapy Platform to generate a pipeline of candidates to treat cancer and other difficult-to-treat diseases.

Posted-In: Short Ideas Technicals Options Movers Trading Ideas

 

Related Articles (CLDX)

Around the Web, We're Loving...

Partner Network

Get Benzinga's Newsletters